Viewing Study NCT02116933


Ignite Creation Date: 2025-12-25 @ 3:01 AM
Ignite Modification Date: 2026-03-06 @ 10:11 PM
Study NCT ID: NCT02116933
Status: UNKNOWN
Last Update Posted: 2015-05-13
First Post: 2014-03-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Grafting of Autologous Adipose Stromal Cell Trial
Sponsor: Tower Outpatient Surgical Center
Organization:

Study Overview

Official Title: Grafting of Autologous Adipose Stromal Cell Trial
Status: UNKNOWN
Status Verified Date: 2015-05
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: GAASC
Brief Summary: Grafting of autologous stromal cell trial is a prospective study comparing routine fat grafting versus stromal vascular fraction enriched fat grafting.
Detailed Description: The purpose of this study is to objectively compare outcomes between autologous fat grafting breast augmentation and stromal vascular fraction enhanced autologous fat grafting for cosmetic breast augmentation in a carefully designed study.

Patients will be given the option of participating in one of two studies:

1. A small, level I study will compare AFG to SVF-enriched AFG in the same patient. One breast will be treated with AFG alone (control) and the other breast with SVF-enriched AFG (experimental).
2. A larger, level II study comparing AFG to SVF-enriched AFG in different patients. The patient will either receive AFG alone in both breasts or SVF-enhanced AFG in both breasts.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: